相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progressive multifocal leukoencephalopathy treated with nivolumab
Ethan Hoang et al.
JOURNAL OF NEUROVIROLOGY (2019)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Can Immune Checkpoint Inhibitors Keep JC Virus in Check?
Igor J. Koralnik
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab
Sebastian Rauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab
Ondine Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+T cell reduction in MS
Vinzenz Fleischer et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+T cell reduction in MS
Vinzenz Fleischer et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene et al.
JOURNAL OF AUTOIMMUNITY (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Martin Martinot et al.
EMERGING INFECTIOUS DISEASES (2018)
Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
Qi Wu et al.
JOURNAL OF IMMUNOLOGY (2017)
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
Antonio Carotenuto et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndrome
Rahsan Gocmen et al.
JOURNAL OF NEUROVIROLOGY (2017)
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
Pei-Ran Ho et al.
LANCET NEUROLOGY (2017)
Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+T-lymphocytopenia treated with mirtazapine and mefloquine
Aruna Nambirajan et al.
NEUROLOGY INDIA (2017)
The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy
A. Q. Reuwer et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature
Christa S. Zerbe et al.
CLINICAL INFECTIOUS DISEASES (2016)
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system
Dennis W. Raisch et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCVA® DxSelect™ antibody assay
Denise Campagnolo et al.
JOURNAL OF NEUROVIROLOGY (2016)
Progressive multifocal leukoencephalopathy in an immunocompetent patient
Nicolien M. van der Kolk et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Repeated decrease of CD4+T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
Matthieu Lavielle et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma
Yutaka Tsutsumi et al.
LEUKEMIA & LYMPHOMA (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Circulating CD4+T-cell number decreases in rheumatoid patients with clinical response to rituximab
Silvia Piantoni et al.
RHEUMATOLOGY INTERNATIONAL (2015)
JC polyomavirus mutants escape antibody-mediated neutralization
Upasana Ray et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis
Dominic Borie et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Rituximab is associated with increased risk of Progressive Multifocal Leukoencephalopathy developing among non-HIV-infected Veterans with Chronic Lymphocytic Leukemia.
Leann B. Norris et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Fatal Case of JC Virus Meningitis Presenting with Hydrocephalus in a Human Immunodeficiency Virus-Seronegative Patient
Shruti P. Agnihotri et al.
ANNALS OF NEUROLOGY (2014)
Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1
Mireia Sospedra et al.
CLINICAL INFECTIOUS DISEASES (2014)
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI
Mike P. Wattjes et al.
CURRENT OPINION IN NEUROLOGY (2014)
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era
J. L. Casado et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7
Karl B. Alstadhaug et al.
JAMA NEUROLOGY (2014)
Association between rituximab use and progressive multifocol lenkoeneepholopathy attiong non-HIV, non-Hodgkin lymphoma Veteran's Administration patients
LeAnn B. Norris et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
JC Virus Antibody Status Underestimates Infection Rates
Joseph R. Berger et al.
ANNALS OF NEUROLOGY (2013)
Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis Association With Clinical Response
J. Melet et al.
ARTHRITIS AND RHEUMATISM (2013)
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants
Caroline F. Ryschkewitsch et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias J. Rummel et al.
LANCET (2013)
Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
Rowan Wathes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
Eugene O. Major et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Increased Program Cell Death-1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy
Chen Sabrina Tan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy
Marco Tuccori et al.
ONCOLOGIST (2010)
Fulminant JC Virus Encephalopathy with Productive Infection of Cortical Pyramidal Neurons
Christian Wuethrich et al.
ANNALS OF NEUROLOGY (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Re: Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized trials
Marco Tuccori et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy
Guillaume Lefevre et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Kenneth R. Carson et al.
LANCET ONCOLOGY (2009)
PML-IRIS in patients with HIV infection Clinical manifestations and treatment with steroids
K. Tan et al.
NEUROLOGY (2009)
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
B. O. Khatri et al.
NEUROLOGY (2009)
Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Blockade of CD11a by efalizurnab in psoriasis patients induces a unique state of T-cell hyporesponsiveness
Emma Guttman-Yassky et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone
Daniele Focosi et al.
ANTIVIRAL RESEARCH (2007)
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis
J. F. Viallard et al.
INFECTION (2007)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
A Langer-Gould et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
JC virus granule cell neuronopathy:: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy
IJ Koralnik et al.
ANNALS OF NEUROLOGY (2005)
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer
C Borg et al.
CANCER (2004)
Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1p36 in patients with proven or possible progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
JOURNAL OF VIROLOGY (2003)
Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab
SL Goldberg et al.
BLOOD (2002)
分享论文
